510(k) K993519
K993519 is an FDA 510(k) premarket notification submitted by Cardiovascular Diagnostics, Inc. for the device "RAPIDPOINT ACCENT, MODEL 2000, RAPIDPOINT COAG HEPARIN TITRATION TEST, RAPIDPOINT COAG PROTAMINE RESPONSE TEST". The FDA issued a decision of Substantially Equivalent on January 14, 2000. The device falls under product code JOX (Analyzer, Heparin, Automated), a Class II device regulated under 21 CFR 864.5680. Cardiovascular Diagnostics, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 14, 2000
- Date Received
- October 18, 1999
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Analyzer, Heparin, Automated
- Device Class
- Class II
- Regulation Number
- 864.5680
- Review Panel
- HE
- Submission Type